Insulet Cash Flow from Operating Activities 2010-2023 | PODD
- Insulet cash flow from operating activities for the quarter ending December 31, 2023 was $0.146B, a 22.44% increase year-over-year.
- Insulet cash flow from operating activities for the twelve months ending December 31, 2023 was $0.291B, a 57.24% increase year-over-year.
- Insulet annual cash flow from operating activities for 2023 was $0.146B, a 22.44% increase from 2022.
- Insulet annual cash flow from operating activities for 2022 was $0.119B, a 274.74% decline from 2021.
- Insulet annual cash flow from operating activities for 2021 was $-0.068B, a 181.07% decline from 2020.
Insulet Annual Cash Flow Ops (Millions of US $) |
|
---|---|
2023 | $146 |
2022 | $119 |
2021 | $-68 |
2020 | $84 |
2019 | $98 |
2018 | $36 |
2017 | $41 |
2016 | $16 |
2015 | $-13 |
2014 | $9 |
2013 | $3 |
2012 | $-29 |
2011 | $-25 |
2010 | $-36 |
2009 | $-49 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $12.066B | $1.697B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $180.939B | 23.69 |
Stryker (SYK) | United States | $123.542B | 29.59 |
Medtronic (MDT) | Ireland | $111.935B | 15.85 |
Boston Scientific (BSX) | United States | $107.817B | 34.34 |
EssilorLuxottica (ESLOY) | France | $101.153B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.922B | 0.00 |
Haleon (HLN) | United Kingdom | $37.990B | 27.73 |
ResMed (RMD) | United States | $31.710B | 29.77 |
Terumo (TRUMY) | Japan | $25.565B | 36.10 |
Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
Zimmer Biomet Holdings (ZBH) | United States | $24.681B | 15.77 |
Baxter (BAX) | United States | $17.958B | 12.77 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.266B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.385B | 27.43 |
BellRing Brands (BRBR) | United States | $7.844B | 36.74 |
Lantheus Holdings (LNTH) | United States | $5.455B | 13.59 |
Haemonetics (HAE) | United States | $4.945B | 24.47 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.129B | 12.52 |
Prestige Consumer Healthcare (PBH) | United States | $3.548B | 16.98 |
Envista Holdings (NVST) | United States | $3.295B | 13.60 |
QuidelOrtho (QDEL) | United States | $2.959B | 16.42 |
Neogen (NEOG) | United States | $2.835B | 27.27 |
TG Therapeutics (TGTX) | United States | $2.776B | 78.09 |
Green Thumb Industries (GTBIF) | United States | $2.714B | 53.75 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.690B | 0.00 |
ICU Medical (ICUI) | United States | $2.565B | 22.63 |
Agios Pharmaceuticals (AGIO) | United States | $1.938B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.927B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.752B | 51.34 |
InMode (INMD) | Israel | $1.560B | 8.29 |
Warby Parker (WRBY) | United States | $1.543B | 0.00 |
Owens & Minor (OMI) | United States | $1.513B | 13.19 |
AdaptHealth (AHCO) | United States | $1.306B | 9.73 |
National Vision Holdings (EYE) | United States | $1.200B | 38.20 |
AtriCure (ATRC) | United States | $1.042B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.032B | 0.00 |
Canopy Growth (CGC) | Canada | $0.983B | 0.00 |
Evolus (EOLS) | United States | $0.799B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.738B | 15.70 |
Cresco Labs (CRLBF) | United States | $0.698B | 0.00 |
Quanterix (QTRX) | United States | $0.644B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.631B | 14.83 |
PetIQ (PETQ) | United States | $0.576B | 18.82 |
Valneva SE (VALN) | France | $0.558B | 0.00 |
Jin Medical (ZJYL) | China | $0.522B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
Surmodics (SRDX) | United States | $0.471B | 29.46 |
ZimVie (ZIMV) | United States | $0.455B | 38.79 |
Biote (BTMD) | United States | $0.443B | 8.50 |
OraSure Technologies (OSUR) | United States | $0.403B | 12.98 |
Aurora Cannabis (ACB) | Canada | $0.382B | 0.00 |
Cerus (CERS) | United States | $0.377B | 0.00 |
Zynex (ZYXI) | United States | $0.345B | 47.22 |
MacroGenics (MGNX) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.260B | 25.77 |
Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
Omeros (OMER) | United States | $0.243B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
Veru (VERU) | United States | $0.215B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
High Tide (HITI) | Canada | $0.182B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.164B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.152B | 73.06 |
InterCure (INCR) | Israel | $0.148B | 24.96 |
FitLife Brands (FTLF) | United States | $0.136B | 19.36 |
Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.104B | 8.94 |
Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
Safety Shot (SHOT) | United States | $0.067B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.96 |
Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
ImmuCell (ICCC) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.08 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
Exagen (XGN) | United States | $0.031B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |